A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma
NCT00423306
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
HEPATOCELLULAR CARCINOMA
Interventions
DRUG:
Darinaparsin
Sponsor
Alaunos Therapeutics